Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in studies of circulating microRNAs: origination, transportation, and distal target regulation. | J Cell Commun Signal | 2023 | 36357651 | PubTator, text mining | PubMed |
| Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. | Clin Exp Med | 2023 | 36271962 | PubTator, text mining | PubMed |
| ATP13A2 is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma. | J Gastrointest Surg | 2023 | 36127552 | PubTator, text mining | PubMed |
| CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway. | Cell Biol Toxicol | 2023 | 35567596 | PubTator, text mining | PubMed |
| Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. | Cell Biol Toxicol | 2023 | 35412187 | PubTator, text mining | PubMed |
| Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity. | Cell Biol Toxicol | 2023 | 35142956 | PubTator, text mining | PubMed |
| Identification of key biomarkers and signaling pathways and analysis of their association with immune cells in immunoglobulin A nephropathy. | Cent Eur J Immunol | 2022 | 36817268 | PubTator, text mining | PubMed |
| Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing. | Front Immunol | 2022 | 36713456 | PubTator, text mining | PubMed |
| RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer. | Front Cell Dev Biol | 2022 | 36684450 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes Related to the Lipid Metabolism of Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis. | Curr Oncol | 2022 | 36661650 | PubTator, text mining | PubMed |
| HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells. | Int J Mol Sci | 2022 | 36614035 | PubTator, text mining | PubMed |
| Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. | Cancers (Basel) | 2022 | 36612133 | PubTator, text mining | PubMed |
| Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression. | J Cancer | 2022 | 36606192 | PubTator, text mining | PubMed |
| Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma. | Front Oncol | 2022 | 36605426 | PubTator, text mining | PubMed |
| Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration. | Front Immunol | 2022 | 36591289 | PubTator, text mining | PubMed |
| Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer. | Cancer Cell Int | 2022 | 36585738 | PubTator, text mining | PubMed |
| An In-Silico Evaluation of Anthraquinones as Potential Inhibitors of DNA Gyrase B of Mycobacterium tuberculosis. | Microorganisms | 2022 | 36557686 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| Crosstalk between Mycotoxins and Intestinal Microbiota and the Alleviation Approach via Microorganisms. | Toxins (Basel) | 2022 | 36548756 | PubTator, text mining | PubMed |
| Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods. | Sci Rep | 2022 | 36543921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=11